In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the
In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the company’s capacity to produce iodine-123 and palladium-103. MDS Nordion currently operates two cyclotrons at the TRIUMF site located on the University of British Columbia campus and a third in Fleurus, Belgium. These facilities supply more than two-thirds of the world’s reactor-produced isotopes.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.